Longitudinal quantification of choriocapillaris flow deficits in persistent placoid maculopathy: a case report.
Choriocapillaris flow deficits
Optical coherence tomography
Persistent placoid maculopathy
Swept source optical coherence tomography angiography
Journal
BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802
Informations de publication
Date de publication:
18 Apr 2023
18 Apr 2023
Historique:
received:
16
10
2022
accepted:
30
03
2023
medline:
20
4
2023
pubmed:
19
4
2023
entrez:
18
04
2023
Statut:
epublish
Résumé
Persistent placoid maculopathy (PPM) is a rare idiopathic chorioretinopathy characterized by choriocapillaris (CC) hypoperfusion. In a case of PPM, we quantified CC flow deficits (FDs) over time and observed an increase in CC perfusion as the visual acuity and outer photoreceptor anatomy improved. A 58-year-old man was diagnosed with PPM in both eyes based on the patient's clinical presentation and imaging. He presented with sudden-onset central scotomas in both eyes for about two months. On referral, the best corrected visual acuity (BCVA) was 20/20 in the right eye and 20/100 in the left eye. Plaque-like yellowish macular lesions were observed bilaterally and autofluorescence imaging showed bilateral hyperautofluorescent lesions. Fluorescein angiography (FA) revealed early-phase hyper-fluorescent staining that intensified in the late phases, while indocyanine green angiography (ICGA) displayed persistent hypofluorescence in both eyes. Foveal centered swept source optical coherence tomography (SS-OCT) B-scans showed bilateral focal deposits on the level of retinal pigment epithelium (RPE) and disruption of outer photoreceptor bands. The CC FDs were quantified on SS-OCT angiography (SS-OCTA) images using a previously published algorithm that was validated. The CC FD% was 12.52% in the right eye and 14.64% in the left eye within a 5 mm circle centered on the fovea. After 5 months of steroid treatment, BCVA remained 20/20 in the right eye and improved to 20/25 in the left eye. On OCT imaging, the outer photoreceptor bands fully recovered in both eyes, while some focal deposits remained along the RPE in the left eye. The CC perfusion in both eyes improved, with CC FD% decreasing from 12.52% to 9.16% in the right eye and from 14.64% to 9.34% in the left eye. Significant impairment of macular CC perfusion was detected after the onset of PPM. Improvement in central macular CC perfusion corresponded with improvements in BCVA and outer retinal anatomy. Our findings suggest that imaging and quantification of CC FDs could serve as a valuable imaging strategy for diagnosing PPM and for following disease progression.
Sections du résumé
BACKGROUND
BACKGROUND
Persistent placoid maculopathy (PPM) is a rare idiopathic chorioretinopathy characterized by choriocapillaris (CC) hypoperfusion. In a case of PPM, we quantified CC flow deficits (FDs) over time and observed an increase in CC perfusion as the visual acuity and outer photoreceptor anatomy improved.
CASE PRESENTATION
METHODS
A 58-year-old man was diagnosed with PPM in both eyes based on the patient's clinical presentation and imaging. He presented with sudden-onset central scotomas in both eyes for about two months. On referral, the best corrected visual acuity (BCVA) was 20/20 in the right eye and 20/100 in the left eye. Plaque-like yellowish macular lesions were observed bilaterally and autofluorescence imaging showed bilateral hyperautofluorescent lesions. Fluorescein angiography (FA) revealed early-phase hyper-fluorescent staining that intensified in the late phases, while indocyanine green angiography (ICGA) displayed persistent hypofluorescence in both eyes. Foveal centered swept source optical coherence tomography (SS-OCT) B-scans showed bilateral focal deposits on the level of retinal pigment epithelium (RPE) and disruption of outer photoreceptor bands. The CC FDs were quantified on SS-OCT angiography (SS-OCTA) images using a previously published algorithm that was validated. The CC FD% was 12.52% in the right eye and 14.64% in the left eye within a 5 mm circle centered on the fovea. After 5 months of steroid treatment, BCVA remained 20/20 in the right eye and improved to 20/25 in the left eye. On OCT imaging, the outer photoreceptor bands fully recovered in both eyes, while some focal deposits remained along the RPE in the left eye. The CC perfusion in both eyes improved, with CC FD% decreasing from 12.52% to 9.16% in the right eye and from 14.64% to 9.34% in the left eye.
CONCLUSIONS
CONCLUSIONS
Significant impairment of macular CC perfusion was detected after the onset of PPM. Improvement in central macular CC perfusion corresponded with improvements in BCVA and outer retinal anatomy. Our findings suggest that imaging and quantification of CC FDs could serve as a valuable imaging strategy for diagnosing PPM and for following disease progression.
Identifiants
pubmed: 37072720
doi: 10.1186/s12886-023-02894-5
pii: 10.1186/s12886-023-02894-5
pmc: PMC10111074
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
161Subventions
Organisme : NEI NIH HHS
ID : R01EY028753
Pays : United States
Informations de copyright
© 2023. The Author(s).
Références
Retina. 2018 Oct;38(10):1881-1895
pubmed: 30148750
Opt Express. 2008 Jul 21;16(15):11438-52
pubmed: 18648464
Am J Ophthalmol. 2020 Dec;220:115-127
pubmed: 32621895
Retina. 2015 Aug;35(8):1531-9
pubmed: 25741814
Ophthalmol Retina. 2017 Jan - Feb;1(1):77-91
pubmed: 31047399
Opt Express. 2012 Sep 24;20(20):22796-812
pubmed: 23037430
Opt Express. 2011 Jan 17;19(2):1271-83
pubmed: 21263668
Ophthalmic Surg Lasers Imaging Retina. 2017 Dec 1;48(12):1026-1031
pubmed: 29253308
JAMA Ophthalmol. 2014 Jan;132(1):38-49
pubmed: 24310266
Opt Express. 2007 Oct 1;15(20):12636-53
pubmed: 19550532
J Biomed Opt. 2010 Jan-Feb;15(1):016029
pubmed: 20210473
Am J Ophthalmol Case Rep. 2022 May 02;26:101563
pubmed: 35572609
Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1499-1505
pubmed: 28273316
Trans Am Ophthalmol Soc. 2006;104:108-20
pubmed: 17471331
Biomed Opt Express. 2017 Jan 24;8(2):1056-1082
pubmed: 28271003
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT585-90
pubmed: 27547891